Chris Lau

Chris Lau

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

Twitter Stock Just Might Rise Back to the $40 Level

Twitter stock is up alongside Snap and Facebook but a revenue beat and stronger profits this year may boost its share price.

7 Energy Stocks to Buy on the Resurgence of the Oil Boom

Higher oil prices could restart the oil boom resurgence that previously ended years ago. This makes several energy stocks appealing buys now.

At This Point, Only a Very Cold Winter Can Move CHK Stock

Warm weather in the last few weeks sent natural gas prices lower and leaving CHK stock in shambles without a lot of hope for improvement.

Acasti Pharma Stock Could Soar Above $3 Soon

When Acasti posts Phase 3 trial results, ACST stock could re-visit recent highs. Here's why you should pay attention to the stock now.

Nokia Stock Can Climb to $5.00

NOK stock fell sharply in the wake of its Q3 results. But Nokia stock can rally meaningfully as NOK cut its costs and wins more 5G deals.

A Recent FDA Approval Will Be Huge in Moving Amarin Stock

FDA approval of Vascepa in use for cardiovascular events just widened Amarin’s revenue potential. Amarin stock should have a banner 2020.

Why Qualcomm Stock Will Break Out to the Upside

Qualcomm has a lot in store for 2020 from 5G chips for Apple, ARM processors for laptops, and much more. That's good for QCOM stock.

7 Investing Resolutions to Follow in 2020

While you're going to the gym and starting a diet, why not make some investing resolutions? Try to avoid fad stocks and demand dividends.

Troubles for Aurora Cannabis Are Bound to Continue in 2020

After an unrelenting decline since the start of 2019, Aurora Cannabis (NYSE:ACB) may continue its dramatic drop in 2020. The sudden executive changes, a stock…

7 Excellent Value Stocks to Buy for 2020  

As investors shift their money to value stocks in 2020, check out these names that all have massive upside potential ahead.